(3S)-2-(3-fluoro-2,6-dioxo-piperidin-3-yl)-isoindol-1,3-dione | 252053-45-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: (3S)-2-(3-fluoro-2,6-dioxo-piperidin-3-yl)-isoindol-1,3-dione
• 英文别名: (3S)-3-fluorothalidomide；(S)-3'-fluorothalidomide；(S)-fluoro-thalidomide；2-[(3S)-3-fluoro-2,6-dioxopiperidin-3-yl]isoindole-1,3-dione
• CAS: 252053-45-5
• 化学式: C₁₃H₉FN₂O₄
• 分子量: 276.224
• InChiKey: SCJORWDJJJWLJD-CYBMUJFWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  20
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  83.6
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (3S)-2-(3-fluoro-2,6-dioxo-piperidin-3-yl)-isoindol-1,3-dione 在 potassium carbonate 、 三氟乙酸 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 6.0h， 生成 [(3S)-3-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-3-fluoro-2,6-dioxo-piperidin-1-yl]-acetic acid
  参考文献：
  名称：

  (R)- and (S)-3-Fluorothalidomides:  Isosteric Analogues of Thalidomide

  摘要：

  3-Fluorothalidomide, a nonracemizable isosteric analogue of thalidomide, was successfully prepared by perchloryl fluoride fluorination of a 3-phthalimidopiperidin-2-one derivative followed by RuO2 oxidation, In the preliminary biological evaluation of (R)- and (S)-enantiomers, it was shown that the (S)-isomer was found to be more active than both the (R)-isomer and the racemic thalidomide in lipopolysaccharide-induced TNF-a production enhancement produced from human peripheral blood lymphocytes cultivated in vitro.

  DOI：

  10.1021/ol9902172
• 作为产物：
  描述：

  3-phthalimidyl-piperidin-2-one 在 ruthenium(IV) oxide 4-二甲氨基吡啶 、 sodium periodate 、 三氟乙酸 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 、 水 、 乙酸乙酯 、 乙腈 为溶剂， 反应 3.33h， 生成 (3S)-2-(3-fluoro-2,6-dioxo-piperidin-3-yl)-isoindol-1,3-dione
  参考文献：
  名称：

  (R)- and (S)-3-Fluorothalidomides:  Isosteric Analogues of Thalidomide

  摘要：

  3-Fluorothalidomide, a nonracemizable isosteric analogue of thalidomide, was successfully prepared by perchloryl fluoride fluorination of a 3-phthalimidopiperidin-2-one derivative followed by RuO2 oxidation, In the preliminary biological evaluation of (R)- and (S)-enantiomers, it was shown that the (S)-isomer was found to be more active than both the (R)-isomer and the racemic thalidomide in lipopolysaccharide-induced TNF-a production enhancement produced from human peripheral blood lymphocytes cultivated in vitro.

  DOI：

  10.1021/ol9902172

文献信息

• COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND ASSOCIATED METHODS OF USE
  申请人：Arvinas Operations, Inc.

  公开号：US20220144809A1

  公开（公告）日：2022-05-12

  Bifunctional compounds, which find utility as modulators of androgen receptor (AR), are described herein. In particular, the bifunctional compounds of the present disclosure contain on one end a moiety that binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds AR, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aberrant regulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

  本文描述了具有雄激素受体（AR）调节剂作用的双功能化合物。特别地，本公开的双功能化合物在一端含有结合到cereblon E3泛素连接酶的基团，在另一端含有结合到AR的基团，使得靶蛋白质位于泛素连接酶附近以促进靶蛋白质的降解（和抑制）。本公开的双功能化合物表现出与靶蛋白质的降解/抑制相关的广泛的药理活性。使用本公开的化合物和组合物治疗或预防由靶蛋白质异常调节引起的疾病或障碍。
• [EN] COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND ASSOCIATED METHODS OF USE<br/>[FR] COMPOSÉS ET MÉTHODES POUR LA DÉGRADATION CIBLÉE DU RÉCEPTEUR DES ANDROGÈNES ET MÉTHODES D'UTILISATION ASSOCIÉES
  申请人：ARVINAS OPERATIONS INC

  公开号：WO2022098544A1

  公开（公告）日：2022-05-12

  Bifunctional compounds, which find utility as modulators of androgen receptor (AR), are described herein. In particular, the bifunctional compounds of the present disclosure contain on one end a moiety that binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds AR, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aberrant regulation of the target protein are treated or prevented with compounds and compositions of the present disclosure..

  本文描述了具有雄激素受体（AR）调节剂作用的双功能化合物。具体而言，本公开的双功能化合物在一端包含结合到 cereblon E3 泛素连接酶的一个部分，在另一端包含结合 AR 的一个部分，从而使目标蛋白质靠近泛素连接酶，以促进目标蛋白质的降解（和抑制）。本公开的双功能化合物表现出与目标蛋白质的降解/抑制相关的广泛药理活性。使用本公开的化合物和组合物治疗或预防由于目标蛋白质异常调节而导致的疾病或障碍。
• Asymmetric Synthesis of Both Mirror Images of 3′-Fluorothalidomide by Enantiodivergent Fluorination Using a Single, Cinchona Alkaloid
  作者：Takeshi Yamamoto、Yuka Suzuki、Emi Ito、Etsuko Tokunaga、Norio Shibata

  DOI：10.1021/ol102818g

  日期：2011.2.4

  Enantiomerically pure 3'-fluorothalidomide (2) was successfully synthesized by enantiodivergent electrophilic fluorination using a combination of cinchona alkaloids and N-fluorobenzenesulfonimide (NFSI) as the key reaction. Importantly, a single chiral molecule, dihydroquinine (DHQ), allowed access to the mirror image form of 3'-fluorothalidimide by the choice of additives. While the use of TMEDA gave fluorinated (S)-4, the precursor of 2, with 78% ee, Cu(acac)(2)/bipy, afforded the antipode, (R)-4, In 77% ee.
• (<i>R</i>)- and (<i>S</i>)-3-Fluorothalidomides:  Isosteric Analogues of Thalidomide
  作者：Yoshio Takeuchi、Tomoki Shiragami、Kenichi Kimura、Emiko Suzuki、Norio Shibata

  DOI：10.1021/ol9902172

  日期：1999.11.1

  3-Fluorothalidomide, a nonracemizable isosteric analogue of thalidomide, was successfully prepared by perchloryl fluoride fluorination of a 3-phthalimidopiperidin-2-one derivative followed by RuO2 oxidation, In the preliminary biological evaluation of (R)- and (S)-enantiomers, it was shown that the (S)-isomer was found to be more active than both the (R)-isomer and the racemic thalidomide in lipopolysaccharide-induced TNF-a production enhancement produced from human peripheral blood lymphocytes cultivated in vitro.